Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare and digital health company focused on portable, semiconductor-based ultrasound technology and ultrasound software solutions. The Butterfly Network news feed on Stock Titan highlights company announcements that relate to its handheld ultrasound devices, Ultrasound-on-Chip™ semiconductor platform, enterprise software and AI initiatives.
Investors and healthcare professionals following BFLY news will see updates on financial results and guidance, such as quarterly earnings releases and preliminary revenue expectations furnished through press releases and 8-K filings. These items often include commentary on revenue growth, cash usage, chip development milestones and the progress of enterprise offerings like Compass™ and Compass AI™.
News coverage also features product and platform developments, including launches of new software capabilities such as Compass AI, announcements about AI-enabled clinical tools like Auto B-line Counter or a Gestational Age AI tool, and information about developer-focused initiatives like Butterfly Garden™ and the planned Beam Steering API. These stories provide insight into how Butterfly is expanding its imaging platform and exposing core capabilities to partners and developers.
Another recurring theme in Butterfly Network news is global health and clinical impact. Press releases describe programs in Sub-Saharan Africa involving handheld probes, training and AI tools for obstetric ultrasound, as well as clinical publications that examine how Butterfly’s devices and software can affect workflows, costs and provider economics in hospital systems.
In addition, the BFLY news stream includes capital markets and corporate updates, such as participation in healthcare investor conferences, executive appointments and SEC-reported events like the NYSE’s decision to delist Butterfly’s public warrants while leaving the common stock listing under BFLY unchanged. For readers tracking Butterfly Network, this page offers a consolidated view of operational, financial, technological and regulatory developments as they are publicly disclosed.
Butterfly Network, Inc. (NYSE: BFLY) will report its fourth quarter 2022 financial results and provide a business update on February 28, 2023, before market opening. The conference call will be hosted by Dr. Jonathan Rothberg, Chairman and Interim CEO, and Heather Getz, Executive Vice-President and CFO, at 8:30 am ET. Interested parties can access the call via Butterfly's Investor Relations website. The company, known for its handheld ultrasound technology, aims to democratize medical imaging globally, addressing the needs of 4.7 billion people lacking access to ultrasound.
Butterfly Network, Inc. (NYSE: BFLY) announced the successful completion of phase one of its $5 million deployment and training program in Kenya, funded by the Bill & Melinda Gates Foundation. The initiative distributed 500 Butterfly iQ+ devices to mid-level healthcare practitioners, significantly enhancing maternal-fetal care. Initial data shows an impressive adoption rate, with over 90% of trained respondents identifying high-risk conditions. The program aims to equip 1,000 healthcare workers in Sub-Saharan Africa and will continue with a second phase in South Africa.
Butterfly Network, Inc. (NYSE: BFLY) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference from January 9-12, 2023, in San Francisco, California. Key executives, Darius Shahida and Heather Getz, will present on January 12 at 9:00 am PT at the Westin St. Francis Hotel. The presentation will be available via a live webcast. Butterfly Network is recognized for its innovative handheld, whole-body ultrasound technology aimed at improving global health equity.
Butterfly Network, Inc. (NYSE: BFLY) announces the departure of Dr. Todd Fruchterman as President and CEO. The decision was mutual, and Dr. Fruchterman will assist with the transition until the end of the year. Jonathan Rothberg, the Company’s Founder and Chairman, expressed gratitude for Dr. Fruchterman’s contributions. Dr. Rothberg will assume the role of Interim CEO during the search for a permanent replacement, ensuring continuity in the Company’s operations and leadership.
Butterfly Network reported a 34.2% increase in total revenue for Q3 2022, totaling $19.6 million, compared to $14.6 million in Q3 2021. The growth was driven by a 21.3% rise in product revenue and a 71.1% surge in software services. Gross profit improved significantly to $11.0 million, with a gross margin of 56.0%. Despite rising operating expenses of $57.0 million and a net loss of $54.7 million, the company has $273 million in cash reserves. Guidance for 2022 revenue is revised to $73-$76 million amid market challenges.
Butterfly Network, Inc. (NYSE: BFLY) announced it will release its third quarter 2022 financial results on November 3, 2022, prior to market opening. A conference call hosted by CEO Dr. Todd Fruchterman and CFO Heather Getz will take place at 8:30 am ET on the same day to discuss the financial performance and operational progress. The call will be accessible via a live webcast on Butterfly's Investor Relations website. The company continues to innovate in handheld ultrasound technology, aiming to enhance global health equity.
Butterfly Network, Inc. (NYSE: BFLY) has launched its new Proficiency Management Solution as part of its enterprise imaging platform, Butterfly Blueprint™. This solution aims to enhance ultrasound utilization among emergency physicians by standardizing bedside ultrasound assessments. Key features include customizable proficiency requirements and data analysis tools to assess ultrasound's impact on clinical care. The solution will be showcased at ACEP22 from October 1-4, 2022. Experts believe it will facilitate broader adoption of ultrasound in emergency medicine.
Butterfly Network (NYSE: BFLY) has announced the deployment of 500 Butterfly iQ+ devices in Kenya, aided by a
VitalConnect has appointed Heather C. Getz to its Board of Directors, adding over 25 years of financial and healthcare leadership experience. Getz, currently the CFO of Butterfly Network Inc. (BFLY), brings expertise in finance, investor relations, and strategic planning. She has a track record of driving revenue growth and successful acquisitions, particularly in the cardiac monitoring field. The board believes her skills will enhance VitalConnect's competitive edge and boost shareholder value in remote patient management.
Butterfly Network, Inc. (NYSE: BFLY) has filed a motion to dismiss claims from a patent infringement lawsuit initiated by FUJIFILM Sonosite on March 9, 2022. Butterfly argues that the lawsuit is baseless and an attempt to distract from FUJIFILM's failure to innovate. The company emphasizes its advancements in handheld ultrasound technology, asserting that it has over 800 patents and applications. Butterfly aims to democratize medical imaging, making high-quality ultrasound accessible globally. The company will defend its innovations and intellectual property vigorously.
FAQ
What is the current stock price of Butterfly Network (BFLY)?
What is the market cap of Butterfly Network (BFLY)?
